About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 929840, 5 pages
http://dx.doi.org/10.1155/2013/929840
Clinical Study

TET2 Mutations in Ph-Negative Myeloproliferative Neoplasms: Identification of Three Novel Mutations and Relationship with Clinical and Laboratory Findings

1Bleeding and Thrombotic Disorders Unit, Department of Hematology, Ospedale Civile dello “Spirito Santo”, 65124 Pescara, Italy
2Atherosclerosis and Thrombosis Unit, IRCCS “Casa Sollievo della Sofferenza”, 71013 San Giovanni Rotondo, Italy
3Laboratory of Molecular Biology, Department of Hematology, Ospedale Civile dello “Spirito Santo”, 65124 Pescara, Italy
4Department of Medical Genetics, Foggia University, 71100 Foggia, Italy

Received 2 April 2013; Accepted 9 May 2013

Academic Editor: Luca Arcaini

Copyright © 2013 Andrea Patriarca et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Andrea Patriarca, Donatella Colaizzo, Gianluca Tiscia, et al., “TET2 Mutations in Ph-Negative Myeloproliferative Neoplasms: Identification of Three Novel Mutations and Relationship with Clinical and Laboratory Findings,” BioMed Research International, vol. 2013, Article ID 929840, 5 pages, 2013. doi:10.1155/2013/929840